| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
48,955 |
45,558 |
$7.43M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30,443 |
28,119 |
$6.25M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,086 |
10,308 |
$2.99M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
9,901 |
9,044 |
$1.52M |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,057 |
4,703 |
$1.11M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13,891 |
13,054 |
$1.07M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
875 |
831 |
$810K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,846 |
6,792 |
$594K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,037 |
10,231 |
$481K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,618 |
13,211 |
$369K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,568 |
4,916 |
$339K |
| 71045 |
Radiologic examination, chest; single view |
9,920 |
9,240 |
$302K |
| 80053 |
Comprehensive metabolic panel |
32,743 |
29,683 |
$277K |
| J3490 |
Unclassified drugs |
47,034 |
20,100 |
$243K |
| 71046 |
Radiologic examination, chest; 2 views |
4,104 |
3,896 |
$241K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
32,703 |
29,679 |
$236K |
| 74022 |
|
2,255 |
2,128 |
$234K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,298 |
5,653 |
$167K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14,336 |
11,891 |
$156K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,324 |
2,916 |
$150K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
195 |
177 |
$149K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,244 |
2,115 |
$130K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,266 |
3,017 |
$111K |
| 81025 |
|
13,656 |
12,600 |
$105K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,125 |
1,954 |
$95K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,782 |
2,506 |
$84K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,782 |
2,506 |
$84K |
| 84484 |
|
10,882 |
9,474 |
$83K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
518 |
456 |
$79K |
| 87428 |
|
985 |
902 |
$68K |
| 81001 |
|
14,493 |
12,875 |
$51K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,558 |
8,460 |
$50K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,193 |
800 |
$48K |
| 83880 |
|
2,063 |
1,940 |
$47K |
| 81003 |
|
19,489 |
18,275 |
$45K |
| 83690 |
|
6,683 |
6,194 |
$43K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,521 |
2,343 |
$42K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
649 |
468 |
$41K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
840 |
784 |
$41K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
614 |
291 |
$38K |
| 80305 |
|
2,897 |
2,661 |
$37K |
| 36415 |
Collection of venous blood by venipuncture |
17,272 |
14,940 |
$37K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,546 |
2,384 |
$35K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
240 |
71 |
$32K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
491 |
443 |
$32K |
| 85730 |
|
6,810 |
6,409 |
$30K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
62 |
54 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,162 |
976 |
$24K |
| 77336 |
|
416 |
159 |
$22K |
| 85610 |
|
7,404 |
6,992 |
$22K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,158 |
8,373 |
$17K |
| 81513 |
|
818 |
691 |
$17K |
| 87430 |
|
1,196 |
1,171 |
$16K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
14 |
12 |
$16K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
541 |
439 |
$14K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,596 |
1,422 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
945 |
853 |
$13K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
38 |
37 |
$13K |
| 83605 |
|
1,410 |
1,303 |
$11K |
| 83735 |
|
2,008 |
1,788 |
$11K |
| 82550 |
|
2,488 |
2,369 |
$11K |
| 73610 |
|
90 |
81 |
$9K |
| 74019 |
|
117 |
112 |
$9K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
101 |
26 |
$9K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
25 |
25 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,333 |
2,138 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
277 |
206 |
$8K |
| 87040 |
|
794 |
548 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
91 |
67 |
$7K |
| 87088 |
|
1,049 |
1,020 |
$7K |
| 97597 |
|
468 |
267 |
$7K |
| 87081 |
|
1,134 |
1,110 |
$7K |
| 94761 |
|
544 |
428 |
$7K |
| 85379 |
|
801 |
729 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
219 |
208 |
$6K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,447 |
1,280 |
$6K |
| G0378 |
Hospital observation service, per hour |
195 |
97 |
$6K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,271 |
1,944 |
$6K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
30 |
26 |
$6K |
| 73130 |
|
58 |
55 |
$6K |
| 73030 |
|
62 |
56 |
$6K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
106 |
44 |
$5K |
| A9270 |
Non-covered item or service |
24,255 |
15,466 |
$5K |
| 82962 |
|
2,632 |
1,071 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
95 |
89 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
369 |
262 |
$5K |
| 73562 |
|
38 |
37 |
$5K |
| 95811 |
|
12 |
12 |
$5K |
| 84702 |
|
392 |
344 |
$4K |
| 86850 |
|
358 |
310 |
$4K |
| 77300 |
|
31 |
25 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
196 |
163 |
$4K |
| 86780 |
|
262 |
196 |
$4K |
| 88304 |
|
36 |
27 |
$4K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
811 |
726 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
359 |
230 |
$4K |
| 87420 |
|
270 |
265 |
$4K |
| 17250 |
|
52 |
26 |
$4K |
| V2632 |
Posterior chamber intraocular lens |
471 |
339 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
13 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
61 |
59 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,968 |
2,661 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
351 |
312 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,039 |
620 |
$3K |
| 73630 |
|
43 |
38 |
$3K |
| 74018 |
|
33 |
33 |
$3K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
51 |
26 |
$2K |
| 86803 |
|
138 |
112 |
$2K |
| 87210 |
|
512 |
488 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
967 |
876 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
14 |
13 |
$2K |
| 87077 |
|
260 |
222 |
$2K |
| 82805 |
|
77 |
67 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
43 |
43 |
$2K |
| 86901 |
|
545 |
445 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
447 |
429 |
$2K |
| 86900 |
|
545 |
445 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
194 |
163 |
$2K |
| 85027 |
|
297 |
268 |
$2K |
| 80061 |
Lipid panel |
108 |
100 |
$1K |
| 68841 |
|
152 |
105 |
$1K |
| J7510 |
Prednisolone oral, per 5 mg |
220 |
199 |
$1K |
| 94060 |
|
18 |
13 |
$1K |
| 86762 |
|
56 |
43 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
329 |
239 |
$1K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
200 |
177 |
$1K |
| 86787 |
|
58 |
45 |
$975.44 |
| 82731 |
|
13 |
12 |
$952.66 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
22 |
12 |
$924.37 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
29 |
26 |
$922.42 |
| 82803 |
|
57 |
51 |
$841.79 |
| J1096 |
Dexamethasone, lacrimal ophthalmic insert, 0.1 mg |
160 |
107 |
$826.52 |
| 59025 |
Fetal non-stress test |
14 |
12 |
$775.26 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
397 |
375 |
$733.22 |
| 82948 |
|
189 |
127 |
$672.56 |
| 00142 |
|
247 |
215 |
$610.62 |
| 87186 |
|
74 |
66 |
$582.80 |
| 96376 |
|
27 |
24 |
$535.05 |
| 94729 |
|
17 |
12 |
$496.00 |
| 94726 |
|
17 |
12 |
$490.34 |
| 84100 |
|
129 |
123 |
$449.51 |
| 85660 |
|
61 |
48 |
$438.30 |
| 87340 |
|
38 |
28 |
$426.95 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
677 |
475 |
$420.55 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
193 |
175 |
$364.60 |
| J2704 |
Injection, propofol, 10 mg |
190 |
167 |
$352.72 |
| 80143 |
|
45 |
37 |
$323.42 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16 |
15 |
$315.69 |
| 90715 |
|
14 |
13 |
$289.59 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
114 |
89 |
$286.72 |
| 86885 |
|
50 |
49 |
$236.54 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
273 |
258 |
$213.98 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
43 |
40 |
$130.01 |
| 82570 |
|
16 |
12 |
$107.30 |
| 84439 |
|
12 |
12 |
$97.27 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
40 |
39 |
$83.78 |
| 84550 |
|
15 |
12 |
$82.40 |
| 84156 |
|
16 |
12 |
$76.04 |
| 82010 |
|
17 |
12 |
$75.30 |
| C9113 |
Injection, pantoprazole sodium, per vial |
17 |
12 |
$53.75 |
| 80179 |
|
28 |
25 |
$42.11 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
26 |
24 |
$36.94 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
29 |
28 |
$29.45 |
| A6213 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
17 |
12 |
$29.42 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
17 |
14 |
$21.35 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
324 |
208 |
$13.47 |
| J0173 |
Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg |
49 |
35 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
46 |
26 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
225 |
192 |
$0.00 |